Literature DB >> 1892759

Sarcomas in north west England: I. Histopathological peer review.

M Harris1, A L Hartley, V Blair, J M Birch, S S Banerjee, A J Freemont, J McClure, L J McWilliam.   

Abstract

A total of 468 cases of bone, soft tissue and visceral sarcomas (and certain other tumours) diagnosed during the years 1982-84 in North West England were entered in a study of histopathological peer review, incidence and survival. This paper describes the effects of peer review. Material was reviewed by a panel of five pathologists for 413 of the 450 cases originally registered as sarcomas with the Regional Cancer Registry. The diagnosis of sarcomas was confirmed in 76% cases and and there was agreement on sub-type for 53% cases. Measures of agreement were lowest for the two sub-types most commonly diagnosed i.e. malignant fibrous histiocytoma and leiomyosarcoma. Degree of agreement between individual pathologists and final panel diagnosis was also very variable but never less than 65%. It is concluded that second opinion is essential in cases of presumed sarcomas for studies of incidence and aetiology and to ensure that appropriate treatment is selected.

Entities:  

Mesh:

Year:  1991        PMID: 1892759      PMCID: PMC1977501          DOI: 10.1038/bjc.1991.298

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  4 in total

1.  Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experience.

Authors:  M Shiraki; H T Enterline; J J Brooks; N S Cooper; S Hirschl; J A Roth; U N Rao; F M Enzinger; D A Amato; E C Borden
Journal:  Cancer       Date:  1989-07-15       Impact factor: 6.860

2.  Quality assurance of histopathologic diagnoses: a prospective audit of three thousand cases.

Authors:  M E Whitehead; J E Fitzwater; S K Lindley; S B Kern; R C Ulirsch; W F Winecoff
Journal:  Am J Clin Pathol       Date:  1984-04       Impact factor: 2.493

3.  Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience.

Authors:  C A Presant; W O Russell; R W Alexander; Y S Fu
Journal:  J Clin Oncol       Date:  1986-11       Impact factor: 44.544

4.  Histopathology peer review of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience.

Authors:  T A Alvegård; N O Berg
Journal:  J Clin Oncol       Date:  1989-12       Impact factor: 44.544

  4 in total
  19 in total

1.  Malignant peripheral nerve sheath tumours in neurofibromatosis 1.

Authors:  D G R Evans; M E Baser; J McGaughran; S Sharif; E Howard; A Moran
Journal:  J Med Genet       Date:  2002-05       Impact factor: 6.318

2.  A European project on incidence, treatment, and outcome of sarcoma.

Authors:  Giuseppe Mastrangelo; Emanuela Fadda; Luca Cegolon; Maria C Montesco; Isabel Ray-Coquard; Alessandra Buja; Ugo Fedeli; Alvise Frasson; Paolo Spolaore; Carlo R Rossi
Journal:  BMC Public Health       Date:  2010-04-12       Impact factor: 3.295

3.  Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region.

Authors:  Antoine Lurkin; Francoise Ducimetière; Dominique Ranchère Vince; Anne-Valérie Decouvelaere; Dominic Cellier; François N Gilly; Dimitri Salameire; Pierre Biron; Guy de Laroche; Jean Yves Blay; Isabelle Ray-Coquard
Journal:  BMC Cancer       Date:  2010-04-19       Impact factor: 4.430

4.  Soft tissue and visceral sarcomas in Irish patients. Interim analysis of data obtained by the Dublin Soft Tissue Tumour Panel.

Authors:  E F Gaffney; P A Dervan; M M McCabe; K Sheahan; E W Kay; M Leader; J Doyle; P A Daly; J J Fennelly; D N Carney
Journal:  Ir J Med Sci       Date:  1994-05       Impact factor: 1.568

5.  [Importance of specialized centers in diagnosis and treatment of extremity-soft tissue sarcomas. Review of 603 cases].

Authors:  M Lehnhardt; A Daigeler; H H Homann; J Hauser; S Langer; L Steinsträsser; C Soimaru; A Puls; H U Steinau
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

6.  Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions.

Authors:  I Ray-Coquard; M C Montesco; J M Coindre; A P Dei Tos; A Lurkin; D Ranchère-Vince; A Vecchiato; A V Decouvelaere; S Mathoulin-Pélissier; S Albert; P Cousin; D Cellier; L Toffolatti; C R Rossi; J Y Blay
Journal:  Ann Oncol       Date:  2012-02-13       Impact factor: 32.976

7.  Audit of tumour histopathology reviewed by a regional oncology centre.

Authors:  R J Prescott; S Wells; D L Bisset; S S Banerjee; M Harris
Journal:  J Clin Pathol       Date:  1995-03       Impact factor: 3.411

8.  Histopathologic review of previously negative prostatic core needle biopsies following a new diagnosis of adenocarcinoma of the prostate by core needle biopsies: implications for quality assurance programs.

Authors:  Jay Patel; Lester J Layfield
Journal:  Clin Med Pathol       Date:  2008-09-16

9.  Histopathological diagnostic discrepancies in soft tissue tumours referred to a specialist centre.

Authors:  Khin Thway; Cyril Fisher
Journal:  Sarcoma       Date:  2009-05-27

10.  Multiple primary tumours in a population-based series of patients with histopathologically peer-reviewed sarcomas.

Authors:  A L Hartley; V Blair; M Harris; J M Birch; S S Banerjee; A J Freemont; J McClure; L J McWilliam
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.